Tozadenant Completed Phase 2 / 3 Trials for Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00605553Study to Evaluate SYN115 in Parkinson's Disease